Insights · 5 min read
China's contract research organisations now rank among the world's largest. What their growth means for pharmaceutical, biotech and medical device R&D.
By Jack Wu, Partner
Insights · 10 min read
External restructuring can make a China business more agile across supply chain, HR and finance. The strategies available and when each one makes sense.
By Jack Wu, Partner
Insights · 6 min read
China's R&D spending now matches developed European nations, with incentives to match. How to set up an R&D centre and tailor products to Chinese consumers.
By Jack Wu, Partner
Insights · 6 min read
WFOE, JV, or Representative Office: how to choose the right investment structure in China. Covers ownership, control, capital, and operational scope for each entity type.
By Jack Wu, Partner
Insights · 4 min read
Chinese VAT taxpayers are classified as small-scale or general based on annual sales. The differences that matter and how to apply for general taxpayer status.
By Jack Wu, Partner
Insights · 4 min read
China has steadily liberalised its financial sector since 2017, allowing full foreign ownership in banking, securities, and insurance. A summary of key milestones and implications for investors.
By Jack Wu, Partner
